Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis. (Q42548885)
Jump to navigation
Jump to search
scientific article published on 23 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis. |
scientific article published on 23 April 2015 |
Statements
Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis (English)
Sophie Bustany
Julie Cahu
Géraldine Descamps
Catherine Pellat-Deceunynck
23 April 2015
1 reference
Identifiers
1 reference